Respiratory inflammation and infections in high-performance athletes

Immunology and Cell Biology

Volumn 94, Issue 2, 2016, Pages 124-131

  Gleeson, Maree ^a   Pyne, David B ^b,c  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b AUSTRALIAN INSTITUTE OF SPORT   (Australia)

^c UNIVERSITY OF CANBERRA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYTOKINE; IMMUNOGLOBULIN A; PROBIOTIC AGENT;

ASTHMA; ATHLETE; CLINICAL ASSESSMENT; COLOSTRUM; DIET SUPPLEMENTATION; DISEASE SEVERITY; EXERCISE; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INCIDENCE; LIFESTYLE MODIFICATION; MUCOSAL IMMUNITY; NONHUMAN; RECURRENT DISEASE; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK REDUCTION; SALIVA LEVEL; UPPER RESPIRATORY TRACT INFECTION; ANIMAL; ASTHMA, EXERCISE-INDUCED; ATHLETIC PERFORMANCE; DIETARY SUPPLEMENT; IMMUNOLOGY; INFLAMMATION; PHYSIOLOGY; RESPIRATORY TRACT INFECTIONS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ASTHMA, EXERCISE-INDUCED; ATHLETES; ATHLETIC PERFORMANCE; DIETARY SUPPLEMENTS; EXERCISE; HUMANS; INFLAMMATION; PROBIOTICS; RESPIRATORY TRACT INFECTIONS;

EID: 84983097890     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2015.100     Document Type: Review

References (83)

1. Fricker PA. Infectious problems in athletes: an overview. In: Fields KB, Fricker PA (eds). Medical Problems in Athletes. Blackwell Sciences: Malden, MA, 1997, 3-5.
2. Schwellnus M, Derman W, Lambert M, Rehead C, Page T. Epidemiology of illness during the Super 14 rugby tournament-a prospective cohort study. Br J Sports Med 2011; 45: 310-314.
3. Mountjoy M, Junge A, Alonso JM, Engebretsen L, Dragan I, Gerrard D et al. Sports injuries and illness in the 2009 FINA World Championships (Aquatic). Br J Sports Med 2010; 44: 522-527.
4. Alonso JM, Tscholl P, Engebretsen L, Mountjoy M, Dvorak J, Junge A. Occurrence of injuries and illness during the 2009 IAAF World Athletics Championships. Br J Sports Med 2010; 44: 1100-1105.
5. Engebretsen L, Steffen K, Alonso JM, Aubry M, Dvorak J, Junge A et al. Sports injuries and illnesses during the Winter Olympic Games 2010. Br J Sports Med 2010; 44: 772-780.
6. Engebretsen L, Soligard T, Steffen K, Alonsos JM, Aubry M, Budgett R et al. Sports injuries and illnesses during the London Summer Olympic Games 2012. Br J Sports Med 2013; 47: 407-411.
7. Soligard T, Steffen K, Palmer-Green D, Aunbry M, Grant M-E, Meewisse W et al. Sports injuries and illness in the Sochi 2014 Olympic Winter Games. Br J Sports Med 2014; 49: 441-447.
8. Kingsbury KJ, Kay L, Hjelm M. Contrasting plasma free amino acid patterns in elite athletes: association with fatigue and infection. Br J Sports Med 1998; 32: 25-33.
9. Fricker PA, Gleeson M, Flanagan A, Pyne DB, McDonald WA, Clancy RL. A clinical snapshot: do elite swimmers experience more upper respiratory illness than nonathletes Clin Exerc Physiol 2000; 2: 155-158.
10. Konig D, Grathwohl D, Weinstock C, Northoff H, Berg A. Upper respiratory tract infection in athletes: Influence of lifestyle, type of sport, training effects, and immunostimulant intake. Exerc Immunol Rev 2000; 6: 102-120.
11. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev 2011; 17: 6-63.
12. Reid VL, Gleeson M, Williams N, Clancy RL. Clinical investigation of athletes with persistent fatigue and/or recurrent infections. Br J Sports Med 2004; 38: 42-45.
13. Spence L, Brown WJ, Pyne DB, Nissen MD, Sloots TP, McCormack JG et al. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med Sci Sports Exerc 2007; 39: 577-586.
14. Cox AJ, Gleeson M, Pyne DB, Callister R, Hopkins WG, Fricker PA. Clinical and laboratory evaluation of upper respiratory symptoms in elite athletes. Clin J Sports Med 2008; 18: 438-445.
15. Walsh NP, Gleeson M, Pyne DB, Nieman DC, Dhabhar FS, Shephard RJ et al. Position statement. Part two: Maintaining immune health. Exerc Immunol Rev 2011; 17: 64-103.
16. Hellard P, Avalos M, Guimaraes F, Toussaint J-P, Pyne DB. Training-related risk of common illnesses in elite swimmers over a 4-yr period. Med Sci Sports Exerc 2015; 47: 698-707.
17. Fricker PA, Pyne DB, Saunders PU, Cox AJ, Gleeson M, Telford RD. Influence of training loads on runners on patterns of illness in elite distance runners. Clin J Sport Med 2005; 15: 244-250.
18. Pyne DB, Hopkins WG, Gleeson M, Fricker PA. Characterising the individual performance responses to mild illness in international swimmers. Br J Sports Med 2005; 39: 752-756.
19. Martensson S, Nordebro K, Malm C. High training volumes are associated with a low number of self-reported sick days in elite endurance athletes. J Sports Sci Med 2014; 13: 929-933.
20. He C-S, Bishop NC, Handzlick MK, Muhamad AS, Gleeson M. Sex differences in upper respiratory symptoms prevalence and oral-respiratory mucosal immunity in endurance athletes. Exerc Immunol Rev 2014; 20: 8-22.
21. Himmelstein SA, Robergs RA, Koehler KM, Lewis SL, Qualls CR. Vitamin C supplementation and upper respiratory tract infections in marathon runners. J Exerc Physiol Online 1998; 1: 17.
22. Helenius I, Lumme A, Asthma Haahtela T. Asthma, airways inflammation and treatment in elite athletes. Sports Med 2005; 35: 565-572.
23. Tiollier E, Gomez-Merino D, Burnat P, Jouanin J-C, Bourrilhon C, Filaire E et al. Intense training: mucosal immunity and incidence of respiratory infections. Eur J Appl Physiol 2005; 93: 421-428.
24. Coad S, Gray B, Wehbe G, McLellan C. Physical demands and salivary immunoglobulin A responses of elite Australian rules football athletes to match play. Int J Sports Physiol Perform 2015; 10: 613-617.
25. Gleeson M, McDonald WA, Cripps AW, Pyne DB, Clancy RL, Fricker PA et al. The effect on immunity of long-term intensive training in elite swimmers. Clin Exp Immunol 1995; 102: 210-216.
26. Fricker PA, McDonald WA, Gleeson M, Clancy RL. Exercise-induced hypogammaglobulinemia. Clin J Sports Med 1999; 9: 46-49.
27. Gleeson M, Ginn E, Francis JL. Salivary immunoglobulin monitoring in an elite kayaker. Clin J Sports Med 2000; 10: 206-208.
28. Nieman DC, Hanson DA, Dumke CL, Lind RH, Schooter LR, Gross SJ. Relationships between salivary IgA secretion and upper respiratory tract infection following a 160-km race. J Sports Med Phys Fitness 2006; 46: 158-162.
29. Matthews CE, Ockene IS, Freedson PS, Rosal MC, Merrim PA, Herbert JR. Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med Sci Sports Exerc 2002; 34: 1242-1248.
30. Gleeson M, Bishop NC, Oliveira M, McCauley T, Tauler P, Muhamad AS. Respiratory infection-risk in athletes: association with antigen-stimulated IL-10 production and salivary IgA secretion. Scand J Med Sci Sports 2012; 22: 410-417.
31. Gleeson M, McDonald WA, Pyne DB, Cripps AW, Francis JL, Fricker PA et al. Salivary IgA levels and infection risk in elite swimmers. Med Sci Sports Exerc 1999; 31: 67-73.
32. Neville V, Gleeson M, Polland J. Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med Sci Sports Exerc 2008; 40: 1228-1236.
33. Tsai M-L, Chou K-M, Chang C-K, Fang S-H. Changes in mucosal immunity and antioxidation activity in elite male Taiwanese taekwondo athletes associated with intensive training and rapid weight loss. Br J Sports Med 2011; 45: 729-734.
34. Passali D, Damiani V, Passali GC, Passali FM, Bellusi L. Alterations in rhinosinusal homeoststis in a sportive population: our experience with 106 athletes. Eur Arch Otorhinolaryngol 2004; 261: 502-506.
35. Katelaris CH, Carrozzi FM, Burke TV. A springtime Olympics demands special consideration for allergic athletes. J Allergy Clin Immunol 2000; 106: 260-266.
36. Katelaris CH, Carrozzi FM, Burke TV. Allergic rhinoconjunctivitis in elite athletes-optimal management for quality of life and performance. Sports Med 2003; 33: 401-406.
37. Schwellnus M, Kiessig M, Derman W, Noakes T. Fusafungine reduces symptoms of upper respiratory tract infections (URTI) in runners after a 56 km race. Med Sci Sports Exerc 1997; 30: S396.
38. Cox AJ, Gleeson M, Pyne DB, Saunders PU, Callister R, Fricker PA. Respiratory symptoms and inflammatory responses to DifflamTM throat spray intervention in halfmarathon runners: a randomised controlled trial. Br J Sports Med 2010; 44: 127-133.
39. Alaranta A, Alaranat H, Heliovaara M, Alha P, Palmu P, Helenius I. Allergic rhinitis and pharmacological management in elite athletes. Med Sci Sports Exerc 2005; 37: 707-711.
40. Drobnic F, Freixa A, Casman P, Sanhis J, Guardino X. Assessment of chlorine exposure in swimmers during training. Med Sci Sports Exerc 1996; 28: 271-274.
41. Helenius IJ, Rytilya P, Metso T, Haahtela T, Venege P, Tikkanen HO. Respiratory symptoms, bronchial hyperreactivness and cellular characteristics of induced sputum in elite swimmers. Allergy 1998; 53: 346-452.
42. Bonsignore MR, Morici G, Riccobono L, Profita M, Bonanno A, Paternò A et al. Airway cells after swimming outdoors or in the sea in nonasthmatic athletes. Med Sci Sports Exerc 2003; 35: 1146-1152.
43. Martin N, Lindley MR, Hardadon B, Monteiro WR, Ravord ID. Airway dysfunction and inflammation in pool-and non-pool-based elite athletes. Med Sci Sports Exerc 44: 1433-1439.
44. Morgans R, Owen A, Doran D, Drust B, Morton JP. Prematch salivary secretory immunoglobulin A in soccer players from the 2014 World Cup qualifying campaign. Int J Sports Physiol Perform 2015; 10: 401-403.
45. Bruunsgard H, Galbo H, Halkjaer-Kristensen J, Johansen TL, Maclean DA, Pedersen BK. Exercise-induced increase in interleukin-6 is related to muscle damage. J Physiol 1997; 299: 833-841.
46. Cox AJ, Pyne DB, Gleeson M. Resting plasma and salivary IL-6 concentrations are not correlated in distance runners. Eur J Appl Physiol 2008; 103: 477-479.
47. Gleeson M, McDonald WA, Cripps AW, Pyne DB, Clancy RL, Fricker PA et al. In: Mestecky J (ed). Advances in Mucosal Immunology. Plenum Press: New York, 1995, p 571-574.
48. Gleeson M, Pyne DB, Austin JP, Francis JL, Clancy RL, McDonald WA et al. Epstein-Barr virus reactivation and upper respiratory illness in elite swimmers. Med Sci Sports Exerc 2002; 34: 411-417.
49. Cox AJ, Gleeson M, Pyne DB, Saunders PU, Clancy RL, Fricker PA. Valtrext therapy for Epstein-Barr virus reactivation and upper respiratory symptoms in elite runners. Med Sci Sports Exerc 2004; 36: 1104-1110.
50. Yamauchi R, Shimizu I, Kimura F, Takemura M, Suzuki K, Akama T et al. Virus activation and immune function during intense training in rugby football players. Int J Sports Med 2011; 33: 393-398.
51. Russell MW, Mestecky J, Strober W, Lambrecht BN, Kelsall BL, Cheroutre H. Overview: the mucosal immune system. In: Mestecky J, Strober W, Russell MW, Kelsall BL, Cheoutre H, Lambrecht BN (eds). Mucosal Immunology, 4th edn. Academic Press: Oxford, 2015, p 3-8.
52. Aymeric L, Sansonetti P. Discriminating pathogens from commensals at mucosal surfaces In: Mestecky J, Strober W, Russell MW, Kelsall BL, Cheoutre H, Lambrecht BN (eds). Mucosal Immunology, 4th edn. Academic Press: Oxford, 2015, p 975-803.
53. Kim IJ, Flano E, Woodland DL, Lund FE, Randall TD, Balckman MA. Maintenance of long term gamma-herpesvirus B cell latency is dependent on CD40-mediated development of memory B cells. J Immunol 2003; 171: 886-892.
54. Gleeson M, Hall ST, McDonald WA, Flanagan AJ, Clancy RL. Salivary IgA subclasses and infection risk in elite swimmers. Immunol Cell Biol 1999; 77: 351-355.
55. Putlur P, Foster C, Miskowski JA, Kane MK, Burton SE, Scheett TP et al. Alteration of immune function in women collegiate soccer players and college students. J Sports Sci Med 2004; 3: 234-244.
56. Fahlman MA, Engels H-J. Mucosal IgA and URTI in American college football players: a year longitudinal study. Med Sci Sports Exerc 2005; 37: 374-380.
57. Gleeson M, McDonald WA, Pyne DB, Clancy RL, Cripps AW, Francis JL et al. Immune status and respiratory illness in elite swimmers during a 12-week training cycle. Int J Sports Med 2000; 21: 302-307.
58. Nehlsen-Cannarella SL, Nieman DC, Fagoaga OR, Kellin WJ, Henson DA, Shannon M et al. Salivary immunoglobulins in elite women rowers. Eur J Appl Physiol 2000; 81: 222-228.
59. Nakamua D, Akimoto T, Suzuki S, Kono I. Daily changes of salivary secretory immunoglobulin A and appearance of upper respiratory symptoms during physical training. J Sports Med Phys Fitness 2006; 46: 152-157.
60. Mackinnon LT, Hooper S. Mucosal (secretory) immune responses to exercise of varying intensity and during overtraining. Int J Sports Med 1994; 15: S179-S183.
61. Francis JL, Gleeson M, Pyne DB, Callister R, Clancy RL. Variation of salivary immunoglobulins in exercising and sedentary populations. Med Sci Sports Exerc 2005; 37: 571-578.
62. Gleeson M. Mucosal immune responses and risk of respiratory illness in elite athletes. Exerc Immunol Rev 2000; 6: 5-42.
63. Gleeson M, Pyne DB. Exercise effects on mucosal immunity. Immunol Cell Biol 2000; 78: 536-544.
64. Klentrou P, Cieslak T, MacNeil M, Vintinner A, Plyley M. Effect of moderate exercise on salivary immunoglobulin A and infection risk in humans. Eur J Appl Physiol 2002; 87: 153-158.
65. Cox AJ, Pyne DB, Saunders PU, Callister R, Gleeson M. Cytokine responses to treadmill running in healthy and illness-prone athletes. Med Sci Sports Exerc 2007; 39: 1918-1926.
66. Cox AJ, Pyne DB, Gleeson M, Callister R. Relationship between C-reactive protein concentration and cytokine responses to exercise in healthy and illness-prone runners. Eur J Appl Physiol 2009; 107: 611-614.
67. Cox AJ, Pyne DB, Callister R, Scott R, Fricker PA, Gleeson M. Cytokine gene polymorphisms and risk of upper respiratory symptoms in highly-trained athletes. Exerc Immunol Rev 2010; 16: 8-21.
68. Zehsaz F, Farhangi N, Monfaredan A, Tabatabaei-Seyed M. IL-10 G-1082A gene polymormphism and susceptibility to upper respiratory tract infection among endurance athletes. J Sports Med Phys Fitness 2014; 55: 128-134.
69. Vollmer-Conna U, Piraimo BF, Cameron B, Davenport T, Hickie I, Wakefield D et al. Cytokine polymorphisms have a synergistic effect on severity of acute sickness response to infection. Clin Infect Dis 2008; 47: 1418-1425.
70. Peters EM. Vitamins, immunity and infection risk in athletes. In: Nieman DC, Pedersen BK (eds). Nutrition and Exercise Immunology. CRC Press: Boca Raton, 2000, p 110-115.
71. He C-S, Handzlick MK, Fraser WD, Muhamad AS, Preston H, Richardson A et al. Influence of vitamin D status on respiratory infection incidence and immune function during 4 months of winter training in endurance sport athletes. Exerc Immunol Rev 2013; 19: 86-191.
72. Truong-Tran AQ, Carter J, Ruffin R, Zalewshi PD. New insights into the role of zinc in the respiratory epithelium. Immunol Cell Biol 2001; 79: 170-177.
73. Prassad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized double-blind placebo-controlled trial. Ann Intern Med 2000; 133: 245-252.
74. Wood LG, Garg ML, Smart JM, Scott HA, Barker D, Gibson PG. Manipulating anti-oxidant intake in asthma: a randomised controlled trial. Am J Clin Nutr 2012; 96: 534-543.
75. Scherr JJ, Nieman DC, Schuster T, Habermann J, Rank M, Braun S et al. Non-alchoholic beer reduces inflammation and incidence of respiratory tract illness. Med Sci Sports Exerc 2012; 44: 18-26.
76. Nieman DC, Henson DA, Gross SJ, Jenkins DP, Davis JM, Murphy EA et al. Quercetin reduces illness but not immune perturbations after intense exercise. Med Sci Sports Exerc 2007; 39: 1561-1569.
77. Crooks C, Cross ML, Wall C, Ali A. Effect of bovine colostrum supplementation on respiratory tract mucosal defenses in swimmers. Int J Sports Nutr 2010; 20: 224-235.
78. Shing CM, Peake J, Suzuki K, Okutsu M, Pereira R, Stevenson L et al. Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. J Appl Physiol 2007; 102: 1113-1122.
79. Jones AW, Cameron SJ, Thatcher R, Beecroft MS, Mur LA, Davison G. Effects of bovine colostrum supplementation on upper respiratory illness in active males. Brain Behav Immunol 2014; 39: 194-203.
80. Mero A, Miikkulainen H, Riski J, Pakkanen R, Aalto J, Takala T. Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone and saliva IgA during training. J Appl Physiol 1997; 83: 1144-1151.
81. Gleeson M, Bishop NC, Oliveira M, Pauler P. Daily probiotic's (Lactobacillus casei Shirota) reductions of infections incidence in athletes. Int J Sports Nutr Exerc Metab 2011; 21: 55-64.
82. Clancy RL, Gleeson M, Cox AJ, Callister R, Dorrington M, D'Este C et al. Reversal in fatigued athletes of a defect in interferon secretion after administration of Lactobacillus acidophilus. Br J Sports Med 2006; 40: 351-354.
83. Cox AJ, Pyne DB, Saunders PU, Fricker PA. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 2010; 44: 222-226.